Use of the antimicrobial peptide pardaxin (GE33) to protect against methicillin-resistant Staphylococcus aureus infection in mice with skin injuries

Antimicrobial Agents and Chemotherapy
Han-Ning HuangChang-Jer Wu

Abstract

Antimicrobial peptides (AMPs) have recently been determined to be potential candidates for treating drug-resistant bacterial infections. Pardaxin (GE33), a marine antimicrobial peptide, has been reported to possess antimicrobial function. In this study, we investigated whether pardaxin promoted healing of contaminated wounds in mice. One square centimeter of outer skin was excised from the ventral region of mice, and a lethal dose of methicillin-resistant Staphylococcus aureus (MRSA) was applied in the presence or absence of methicillin, vancomycin, or pardaxin. While untreated mice and mice treated with methicillin died within 3 days, mice treated with pardaxin survived infection. Pardaxin decreased MRSA bacterial counts in the wounded region and also enhanced wound closure. Reepithelialization and dermal maturation were also faster in mice treated with pardaxin than in mice treated with vancomycin. In addition, pardaxin treatment controlled excess recruitment of monocytes and macrophages and increased the expression of vascular endothelial growth factor (VEGF). In conclusion, these results suggest that pardaxin is capable of enhancing wound healing. Furthermore, this study provides an excellent platform for comparing the anti...Continue Reading

References

Dec 16, 1980·Biochimica Et Biophysica Acta·N Primor, A T Tu
Feb 1, 1996·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·A Martin
Mar 29, 1996·The Journal of Biological Chemistry·Y Shai, Z Oren
Sep 2, 1999·The New England Journal of Medicine·A J Singer, R A Clark
Jul 27, 2001·The Journal of Surgical Research·T SvensjöE Eriksson
Jul 12, 2002·Biomaterials·Kelly R KirkerGlenn D Prestwich
Sep 3, 2003·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Patricia A HebdaAlan Wells
Jan 24, 2004·Biomaterials·D GopinathR Jayakumar
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brad SpellbergJohn E Edwards
Jul 26, 2005·Journal of Ethnopharmacology·P J HoughtonA M Deters
Mar 27, 2007·Nature Biotechnology·Monisha G ScottRobert E W Hancock
Aug 13, 2008·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Kathy K H SvobodaMarion K Gordon
Feb 3, 2009·Toxicologic Pathology·Vanesa Ivetić TkalcevićKarmen Brajsa
Jan 29, 2011·Journal of Biomedicine & Biotechnology·Paula S NunesAdriano A S Araújo
May 12, 2011·Peptides·Jung-Chieh HsuJyh-Yih Chen
May 10, 2013·Nature Biotechnology·Jeffrey L Fox

Citations

Jun 7, 2015·Peptides·Jayaram Lakshmaiah Narayana, Jyh-Yih Chen
Jun 6, 2015·Probiotics and Antimicrobial Proteins·Sergey A MiroshnikovIuri B Ivanov
Mar 17, 2017·Journal of Chemical Information and Modeling·Majid JafariFarahnoosh Doustdar
Jan 13, 2018·Science Translational Medicine·Anna de BreijPeter H Nibbering
Apr 13, 2018·Frontiers in Pharmacology·Anja PfalzgraffGünther Weindl
Jun 25, 2019·Frontiers in Microbiology·Chunye ZhangAaron C Ericsson
Sep 23, 2020·Antimicrobial Agents and Chemotherapy·Kirill V OvchinnikovDzung B Diep
Nov 6, 2020·Oxidative Medicine and Cellular Longevity·Raul Santos AlvesReggiani Vilela Gonçalves
Apr 10, 2021·Journal of Biomedical Materials Research. Part a·Neelima AnupRakesh K Tekade

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.